RTX vs. PFE
RTX (RTX Corporation) and PFE (Pfizer Inc.) are both stocks. RTX operates in Aerospace & Defense (Industrials), while PFE operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, RTX returned 15.40%/yr vs 1.92%/yr for PFE. At a 0.31 correlation, their price movements are largely independent.
Performance
RTX vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RTX achieves a -1.44% return, which is significantly lower than PFE's 6.63% return. Over the past 10 years, RTX has outperformed PFE with an annualized return of 15.40%, while PFE has yielded a comparatively lower 1.92% annualized return.
RTX
- 1D
- 3.98%
- 1M
- 4.22%
- YTD
- -1.44%
- 6M
- 5.51%
- 1Y
- 31.55%
- 3Y*
- 25.92%
- 5Y*
- 17.61%
- 10Y*
- 15.40%
PFE
- 1D
- 1.38%
- 1M
- -1.27%
- YTD
- 6.63%
- 6M
- 3.31%
- 1Y
- 17.51%
- 3Y*
- -7.13%
- 5Y*
- -3.25%
- 10Y*
- 1.92%
RTX vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RTX RTX Corporation | -1.44% | 61.44% | 40.76% | -14.44% | 20.01% | 23.27% | -7.70% | 43.82% | -14.66% | 19.13% |
PFE Pfizer Inc. | 6.63% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Correlation
The correlation between RTX and PFE is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jun 2, 1972 | 0.31 |
The correlation between RTX and PFE shifts across timeframes, from 0.12 (1 year) to 0.31 (all time), reflecting how their relationship changes across market environments.
Fundamentals
RTX:
$244.82B
PFE:
$147.23B
RTX:
$5.34
PFE:
$1.31
RTX:
33.62
PFE:
19.58
RTX:
1.34
PFE:
0.35
RTX:
2.70
PFE:
2.32
RTX:
3.69
PFE:
1.63
RTX:
$90.37B
PFE:
$63.32B
RTX:
$18.27B
PFE:
$43.91B
RTX:
$13.81B
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RTX vs. PFE — Risk / Return Rank
RTX
PFE
RTX vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for RTX Corporation (RTX) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RTX | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.59 | ||
| Sortino ratioReturn per unit of downside risk | +0.74 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.15 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.64 | 1.53 | +0.11 |
| Martin ratioReturn relative to average drawdown | 4.69 | 3.15 | +1.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RTX | PFE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.32 | 0.74 | +0.59 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.74 | -0.13 | +0.87 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.56 | 0.08 | +0.48 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.44 | 0.33 | +0.10 |
Drawdowns
RTX vs. PFE - Drawdown Comparison
The maximum RTX drawdown since its inception was -55.14%, smaller than the maximum PFE drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for RTX and PFE.
Loading charts...
Drawdown Indicators
| RTX | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.14% | -69.24% | +14.10% |
Max Drawdown (1Y)Largest decline over 1 year | -19.32% | -11.47% | -7.85% |
Max Drawdown (3Y)Largest decline over 3 years | -29.92% | -40.75% | +10.83% |
Max Drawdown (5Y)Largest decline over 5 years | -32.84% | -58.96% | +26.12% |
Max Drawdown (10Y)Largest decline over 10 years | -51.98% | -58.96% | +6.98% |
Current DrawdownCurrent decline from peak | -15.08% | -46.76% | +31.68% |
Average DrawdownAverage peak-to-trough decline | -13.03% | -22.89% | +9.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.75% | 5.57% | +1.18% |
Volatility
RTX vs. PFE - Volatility Comparison
RTX Corporation (RTX) has a higher volatility of 7.58% compared to Pfizer Inc. (PFE) at 4.28%. This indicates that RTX's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RTX | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.58% | 4.28% | +3.30% |
Volatility (6M)Calculated over the trailing 6-month period | 17.87% | 14.69% | +3.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.97% | 23.88% | +0.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.85% | 25.50% | -1.65% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.73% | 23.88% | +3.85% |
Dividends
RTX vs. PFE - Dividend Comparison
RTX's dividend yield for the trailing twelve months is around 1.54%, less than PFE's 6.70% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 6.70% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
RTX RTX Corporation | 1.54% | 1.46% | 2.14% | 2.76% | 2.14% | 2.33% | 21.21% | 1.96% | 2.66% | 2.13% | 2.39% | 2.66% |
Financials
RTX vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between RTX Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RTX vs. PFE - Profitability Comparison
RTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, RTX Corporation reported a gross profit of 4.59B and revenue of 22.08B. Therefore, the gross margin over that period was 20.8%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
RTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, RTX Corporation reported an operating income of 2.56B and revenue of 22.08B, resulting in an operating margin of 11.6%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
RTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, RTX Corporation reported a net income of 2.06B and revenue of 22.08B, resulting in a net margin of 9.3%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
RTX and PFE have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RTX has higher volatility (7.58%) compared to PFE (4.28%). In terms of maximum drawdown, RTX dropped -55.14% vs PFE's -69.24%.
RTX currently has the higher Sharpe Ratio (1.32 vs 0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RTX and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer